Avio Smart Market Stack Limited (ASMS), formerly known as Bartronics India Limited, in partnership with Huwel Lifesciences, has announced the upcoming launch of Cubo, a compact and cost-efficient RT-PCR platform designed to expand access to advanced molecular diagnostics in India and international markets. Cubo represents a significant step in the evolution of decentralised healthcare delivery. Developed as an indigenous innovation, the platform integrates laboratory-grade RT-PCR performance into a portable format, enabling deployment across a wide range of healthcare environments beyond traditional laboratory settings.
The system is designed to address long-standing challenges in diagnostic access, particularly in regions where samples must be transported to centralised laboratories, often leading to delays and logistical constraints. By enabling accurate testing at or near the point of care, Cubo is expected to reduce turnaround times and streamline diagnostic workflows, supporting faster clinical decision-making.
With its compact design and simplified workflow, Cubo is suitable for use across diverse healthcare settings, including rural clinics, district hospitals, mobile medical units, industrial facilities, and remote or underserved regions. Its intuitive interface is expected to enable broader adoption among healthcare professionals without the need for extensive infrastructure or specialised laboratory environments.
Cubo has been developed as a versatile platform capable of supporting a broad test menu. These include applications in tuberculosis detection, respiratory infections, influenza, viral panels, women’s health diagnostics, sexually transmitted infections, and fever-related conditions, along with potential use in outbreak response scenarios. This adaptability positions the platform to serve a wide spectrum of diagnostic needs while building a scalable installed base.
The launch comes at a time when healthcare systems globally are increasingly shifting toward decentralised diagnostic models that prioritise accessibility, speed, and efficiency. Cubo’s portability, affordability, and multi-application capability are expected to support adoption in both developed and emerging markets.
Commenting on the development, VidhyaSagar Reddy, Managing Director of ASMS, said that expanding access to reliable diagnostics remains a critical priority, and solutions like Cubo can help bridge gaps in underserved areas. Shesheer Kumar, Managing Director of Huwel Lifesciences, noted that the platform combines scientific accuracy with operational simplicity, enabling broader reach and long-term scalability.
The introduction of Cubo reflects a strategic focus by both organisations to strengthen their presence in the rapidly growing health technology sector, with an emphasis on delivering accessible and efficient diagnostic solutions at scale. ASMS operates as a rural financial inclusion and technology company focused on developing integrated rural commerce and agri-tech platforms.
